© 1997 American Heart Association, Inc.
Articles |
N-
-Tosyl-L-Lysine Chloromethylketone Prevents Expression of iNOS in Vascular Smooth Muscle by Blocking Activation of NF-
B
From the Center of Physiology, University Clinic of Frankfurt, Frankfurt, Germany.
Correspondence to V.B. Schini-Kerth, PhD, Zentrum der Physiologie, Klinikum der JWG–Universität, Theodor-Stern-Kai 7, D-60590 Frankfurt/Main, Germany.
 |
Abstract |
|---|
 Top Abstract IntroductionMethodsResultsDiscussionReferences |
|---|
Abstract Certain cytokines and lipopolysaccharide stimulate expression of inducible nitric oxide synthase (iNOS) in vascular smooth muscle, an event that is regulated at the transcriptional level and appears to involve several transcription factors, including nuclear factor
B (NF-B). Since
proteases play an essential role in NF-B activation, experiments
were designed to clarify, in both cultured rat aortic smooth muscle
cells (SMCs) and isolated rat aortas, whether protease
inhibitors affect the interleukin-1ß (IL-1ß)–elicited
expression of iNOS. The formation of NO was assessed by nitrite release
in cultured SMCs and the attenuation of
phenylephrine-induced contraction in aortic rings, the
expression of iNOS by Western blot analysis and reverse
transcription–polymerase chain reaction, and NF-B activity in
nuclear extracts by gel electrophoretic mobility shift assay. Exposure
of cultured SMCs to IL-1ß increased NF-B binding activity within
30 minutes and was associated with nitrite accumulation and the
appearance of iNOS protein 24 hours later. These responses were
abolished in cells that had been exposed to the cytokine in the
presence of the protease inhibitor
N--tosyl-L-lysine
chloromethylketone. Aprotinin and
p-toluenesulfonyl-L-arginine methyl ester, two
other protease inhibitors, also reduced the
cytokine-stimulated release of nitrite and the level of iNOS
protein. Exposure of rat aortic segments without
endothelium to IL-1ß activated NF-B within
30 minutes and was associated with the appearance of iNOS mRNA and an
attenuation of phenylephrine-induced contraction 6
hours later. These responses were blunted when the segments were
incubated with the cytokine and
N--tosyl-L-lysine chloromethyl ketone. The
present observations indicate that protease inhibitors
prevent iNOS expression in both cultured and native vascular SMCs by
blocking the activation of NF-B.
Key Words: inducible nitric oxide synthase • interleukin-1ß • nuclear factor-B • vascular reactivity • vascular smooth muscle
|
Introduction |
|---|
|
TopAbstractIntroductionMethodsResultsDiscussionReferences |
|---|
Nitric oxide is an important physiological regulator of mammalian vascular function in health and disease. In normal blood vessels, NO is generated by a constitutively expressed, calcium/calmodulin–dependent NOS that is localized predominantly in the endothelium.1 Endothelium-derived NO plays a vital role in the local regulation of vascular tone, prevents platelet activation, and helps to maintain VSMCs in a quiescent state.2 3 4
NO can also be generated after transcriptional upregulation of iNOS by
certain cytokines, such as IL-1ß, TNF-, and
endotoxin.5 This sequence of events probably accounts for
the release of NO from denuded blood vessels that have been exposed in
vitro to inflammatory mediators or injured in vivo by either a balloon
catheter or endotoxin.6 7 8 9 Although iNOS expression has
been demonstrated in endothelial cells, fibroblasts,
and macrophages,10 11 12 VSMCs are likely to be the
major cellular source of NO in endothelium-deficient or
injured arteries. Unlike endothelial NOS, iNOS is not
activated by calcium but generates NO at a maximal rate over
long periods of time.6 Similar to the protective roles of
endothelium-derived NO, it is conceivable that
continuous formation of discrete amounts of NO by VSMCs may be
important for maintaining vascular tone, patency, and
nonthrombogenicity at sites of endothelial damage.
However, when NOS induction becomes exaggerated, the release of copious
amounts of NO will cause loss of vascular tone and result in severe
hypotension, such as occurs in septic shock.8
NF-B appears to mediate the cytokine- and
lipopolysaccharide-induced gene transcription that is involved
in the inflammatory response.13 The NF-B family of
transcription factors, including p65 (RelA), c-Rel, RelB, p50, and p52,
share a structurally homologous N-terminal Rel domain that
encodes DNA binding and dimerization functions.14 15 In
addition, p65, c-Rel, and RelB contain potent
transactivator domains.16 The various NF-B
subunits interact to form homodimers and heterodimers, the
best-characterized form of NF-B being a heterodimer composed of a
p50 and a p65 subunit.17 NF-B is constitutively
expressed in the cytosol of many cells albeit bound to
inhibitory protein(s) IB.18 Although the
signal-transduction cascade linking cytokine- and
lipopolysaccharide-receptor stimulation to activation and
nuclear translocation of NF-B is not entirely clear, a final step
involves phosphorylation and proteolytic degradation of
IB.19 20 21 22 Recent studies have suggested that activation
of NF-B also plays a pivotal role in the induction of iNOS. Cognate
sequences for NF-B have been identified in the promoters of both the
human and the mouse gene encoding iNOS.23 24 25 In addition,
the NF-B binding site upstream from the TATA box in the iNOS
promoter of the murine gene has been shown to be necessary but not
sufficient for maximal transcriptional activation of this gene by
lipopolysaccharide.23 25 Recently, protease
inhibitors (eg, TLCK) and antioxidants (eg, pyrrolidine
dithiocarbamate) prevented lipopolysaccharide from stimulating the
expression of iNOS in macrophages presumably by inhibiting the
activation of NF-B.26 27 28 Therefore, we designed
experiments in cultured and native VSMCs to test the hypothesis that
protease inhibitors prevent induction of NOS by interfering
with NF-B activation.
|
Methods |
|---|
|
TopAbstractIntroductionMethodsResultsDiscussionReferences |
|---|
Cell Culture
SMCs were isolated by elastase and collagenase digestion of thoracic aortas from male Wistar rats and characterized by immunocytochemical techniques using a monoclonal antibody against smooth muscle
-actin.29 Cells were cultured in minimum
essential medium containing Earle's salts, 2 mmol/L glutamine,
5 mmol/L Tris-NaOH, 5 mmol/L HEPES-NaOH, (both at pH 7.3),
100 U/mL penicillin, 100 µg/mL streptomycin, and 10% (vol/vol) fetal
bovine serum. Confluent cultures of SMCs were serially passaged with
0.05% trypsin/0.02% EDTA. All experiments were performed with
confluent cultures of cells at passage 4 or higher. SMCs were seeded
into either 24-well multiwell plates for measurement of nitrite
production or Petri dishes (60-mm diameter) for detection of
iNOS protein by Western blot analysis, iNOS mRNA by RT-PCR, and
NF-B binding activity by EMSA. After the cells had reached
confluence, the medium was replaced with serum-free culture medium
containing 0.1% (wt/vol) fatty acid–free BSA. After 24 hours the
incubation medium was replaced again with serum-free culture medium,
and the SMCs were then exposed to IL-1ß for 24 hours or as
indicated.
Preparation of Isolated Blood Vessels
Male Wistar rats were killed and their thoracic aortas removed
and placed in a modified Krebs-Ringer bicarbonate solution containing
(in mmol/L) NaCl 119, KCl 4.7, MgSO4 1.2,
KH2PO4 1.2, CaCl2 1.6,
NaHCO3 25, calcium EDTA 0.026, and glucose 11.1, with
sodium diclofenac (10-6 mol/L) added to prevent
production of vasoactive prostanoids. The aortas were cleaned
of loose connective tissue and cut into either rings (3 to 4 mm
long) for the organ chamber study or segments (5 to 6 mm long) for
both the EMSA and determination of iNOS mRNA by RT-PCR. The
endothelium was removed mechanically from both types of
aortic preparation. Rings were incubated in serum-free culture medium
containing BSA and polymyxin B (1 µg/mL) with or without TLCK,
IL-1ß, or a combination of both for 6 hours at 37°C before the
organ chamber experiment. For both EMSA and RT-PCR, each treatment was
applied to a batch of four segments that had been obtained from four
different rat aortas. Each group of aortic segments was incubated in
serum-free culture medium containing BSA at 37°C. After a 30-minute
rest, the medium was replaced again with fresh, serum-free medium and
the aortic segments were incubated with or without TLCK, IL-1ß, or
both for 30 minutes or as indicated.
Release of Nitrite
Nitrite accumulation was determined by formation of diazo
compounds and the resulting change in absorbance at 570 nm. Aliquots
(150 µL) of conditioned medium from confluent cells were collected
and mixed with an equal volume of Griess reagent [1% sulfanilamide
and 0.1% N-(1-naphthyl)ethylenediamine dihydrochloride
in 2% phosphoric acid]. The mixture was incubated at 20°C for 10
minutes. Concentrations were determined relative to a standard curve
constructed by analyzing aqueous solutions of various concentrations of
sodium nitrite, and background nitrite values corresponding to
nonconditioned medium were subtracted from experimental values.
EMSA
Cells were washed twice with cold HEPES-Tyrode's solution,
harvested by scraping, and incubated in 200 µL of buffer A (HEPES
10 mmol/L, pH 7.9; KCl 10 mmol/L; EDTA 0.1 mmol/L; EGTA
0.1 mmol/L; DL-DTT 1 mmol/L; leupeptin 2 µg/mL;
pepstatin A 2 µg/mL; trypsin inhibitor 10 µg/mL; and
PMSF 88 µg/mL) for 15 minutes at 4°C. The aortic segments were
rapidly frozen and homogenized in liquid N2
with a porcelain mortar and pestle. The frozen tissue powder was
dissolved in 200 µL of ice-cold buffer A for 5 minutes at 4°C.
Thereafter, Nonidet P-40 (0.6%) was added to both types of
preparation. The crude nuclei released by lysis were collected by
microcentrifugation at 15 000g for 30
seconds. The nuclear pellets were resuspended in 50 µL of buffer B
(HEPES 20 mmol/L, pH 7.9; KCl 400 mmol/L; EDTA 1 mmol/L;
EGTA 1 mmol/L; glycerol 10% [wt/vol]; DTT 1 mmol/L; PMSF
88 µg/mL; and 20 µg/mL each of leupeptin, pepstatin A, trypsin
inhibitor, antipain, chymostatin, and aprotinin). Nuclei
were shaken for 15 minutes at 4°C and clarified by
microcentrifugation at 15 000g for 5
minutes. The resulting supernatants contained 1 to 5 mg/mL protein as
assessed by Bradford assay (Bio-Rad Laboratories GmbH) with BSA as the
standard. Nuclear extracts were frozen in liquid N2 and
stored at -70°C. A double-stranded 22-mer
oligonucleotide containing the most common NF-B
consensus sequence ([underlined]
5'-AGTTGAGGGGACTTTCCCAGGC-3', Promega30 ) was
end-labeled with [
-32P]ATP (3000 Ci/mmol, Hartmann
Analytik), using T4 polynucleotide kinase. Binding
reactions were set up with 10 000 counts per minute
32P-labeled DNA, HEPES-NaOH 5 mmol/L (pH 7.5), NaCl
100 mmol/L, DTT 1 mmol/L, 5% glycerol, EDTA 1 mmol/L, 1
µg poly(dI/dC), and 10 to 15 µg of nuclear extract. The binding
reactions were performed at 20°C for 30 minutes and separated by
electrophoresis on a 6% nondenaturating polyacrylamide gel at
135 V for 2 hours in TBE buffer (Tris-borate 89 mmol/L and EDTA
1 mmol/L). On the vacuum-dried gels, the protein-DNA complexes
were visualized by autoradiography and analyzed
by scanning densitometry (ImageMaster, Pharmacia). Competition studies
were performed by adding a twofold excess of unlabeled double-stranded
oligonucleotides to the binding reaction 10 minutes
before the labeled oligonucleotide was added. Samples
were subjected to electrophoresis as described above.
Expression of iNOS mRNA by RT-PCR
The aortic segments were rapidly frozen and
homogenized in liquid N2, and total RNA was
isolated by the method of Chomczynski and Sacchi.31 For
annealing 1 µg of pdN6 to 2 µg total RNA, the reaction mixture (20
µL) was heated to 95°C for 5 minutes and rapidly cooled on ice. RT
was performed with 200 U reverse transcriptase (Life Technology) in
1 mmol/L DTT, 500 µmol/L dNTP, and reaction buffer for 1
hour at 37°C in a final volume of 50 µL. In some reaction mixtures,
reverse transcriptase was omitted to control for contaminating genomic
DNA or cDNA. After denaturation at 95°C for 7 minutes, the
synthesized cDNA was subjected to a 30-cycle PCR. The antisense primer
corresponded to 5'-TCATTGTACTCTGAGGGCTGACACA-3' of the murine
macrophage iNOS cDNA32 and the sense primer to
5'-GCCTTCAACACCAAGGTTGTCTGCA-3'. For normalization of cDNA amounts,
GAPDH transcripts were amplified by PCR in the same PCR reaction. The
antisense primer corresponded to 5'-AGATCCACAACGGATACATT-3' of the rat
and human sequences33 and the sense primer to
5'-TATGACAACTCCCTCAAGAT-3'. The PCR reaction contained 0.4
µmol/L of each primer, 200 µmol/L of each dNTP, 1 U
Taq polymerase (Pharmacia), reaction buffer, and 5 µL cDNA
in a final volume of 50 µL. For Southern blot analysis, the
PCR products were fractionated by size by agarose gel
electrophoresis, transferred to nylon membranes, and hybridized with a
32P-labeled fragment obtained from a plasmid containing
mouse macrophage iNOS cDNA and a 32P-labeled GAPDH
fragment isolated from the PCR reaction. iNOS and GAPDH mRNAs were
localized by autoradiography and analyzed by
scanning densitometry.
Expression of iNOS Protein
Cells were washed twice with cold HEPES-Tyrode's solution,
harvested by scraping, and collected by
microcentrifugation at 3000g for 3 minutes
at 4°C. The cell pellets were resuspended in double-distilled water
and lysed by five freeze/thaw cycles (freezing in liquid N2
and thawing in a 37°C water bath). An equal volume of
homogenization buffer [Tris-HCl 100 mmol/L
(pH 7.4); KCl 2.3% (wt/vol); EDTA 2 mmol/L; DTT 0.2 mmol/L;
PMSF 8.8 µg/mL; and 2 µg/mL each of leupeptin, pepstatin A, trypsin
inhibitor, antipain, chymostatin, and aprotinin] was added
to the cell homogenates, and the cytosols were clarified by
centrifugation at 10 000g for 10 minutes at
4°C. The resulting supernatants contained 1 to 5 mg/mL protein. The
cytosolic fractions were subjected to SDS-PAGE (8% gradient gel). The
separated proteins were electrophoretically transferred to
nitrocellulose membranes (Bio-Rad Laboratories). Nitrocellulose blots
were first incubated with a primary polyclonal rabbit antibody against
iNOS from murine macrophage (dilution 1:2000, overnight at
4°C; kindly provided by Dr Pfeilschifter, JWG–University Clinic,
Frankfurt, Germany) and then with a secondary polyclonal donkey
anti-rabbit immunoglobulin antibody conjugated to horseradish
peroxidase (Amersham International plc) for 1 hour at 20°C. The
immunocomplex was developed using an enhanced horseradish
peroxidase/luminol chemiluminescence reaction (ECL Western blotting
detection reagents, Amersham International plc) and detected with x-ray
film. Prestained molecular-mass markers (Bio-Rad Laboratories) were
used as standards for SDS-PAGE immunoblot analysis.
The autoradiographs were analyzed by scanning densitometry.
Vascular Reactivity Studies
Rings were suspended between two stainless steel stirrups in
organ chambers filled with 10 mL Krebs-Ringer's bicarbonate solution
(37°C, pH 7.4) bubbled with 95% O2 and 5%
CO2. One of the stirrups was anchored to the organ bath
(Schuler-Organbad, kindly made available by Hugo Sachs Elektronik), and
one was connected to a strain gauge (F30, Hugo Sachs Elektronik)
coupled to a recorder for measurement of isometric tension. The
aortic rings were stretched progressively to their optimal length for
maximal contraction (2 to 2.5 g) before phenylephrine
(10-6 mol/L) was added. Once the contraction "plateau"
elicited by phenylephrine was obtained, acetylcholine was
added to demonstrate the effective removal of the
endothelium. The organ chambers were rinsed three times
with control solution. After a 30-minute rest, a
concentration-contraction curve for phenylephrine or a
concentration-relaxation curve for SIN-1 in rings contracted with
phenylephrine (10-6 mol/L) was
constructed.
Statistical Analysis
Results are expressed as mean±SEM. Relaxations to SIN-1 are
expressed as a percent of contraction to phenylephrine. The
negative logarithm of the effective molar concentration of SIN-1
causing 50% relaxation (IC50) was calculated for each
concentration-contraction curve. Statistical evaluation of the data was
performed by Student's t test for paired observations; when
more than two treatments were compared, ANOVA followed by Fisher's
protected least significant difference test was used. A value of
P<.05 was considered statistically significant.
|
Results |
|---|
|
TopAbstractIntroductionMethodsResultsDiscussionReferences |
|---|
Experiments With Cultured Rat Aortic SMCs
Release of Nitrite
The release of nitrite caused by exposure of cultured rat aortic SMCs to IL-1ß for 24 hours was inhibited in a concentration-dependent manner by the addition of TLCK, aprotinin, or L-TAME (Fig 1
). The relative order of potency was
TLCK>aprotinin>L-TAME. Exposure of cells to a protease
inhibitor alone minimally affected the basal release of
nitrite during a 24-hour incubation (Fig 1). The inhibitory
effect of TLCK and aprotinin (10-4 mol/L) on the release
of nitrite evoked by IL-1ß required the presence of the protease
inhibitor during the induction of NOS (Fig 2
and data not shown).
|
|
indicates a
significantly greater release of nitrite than that evoked by
simultaneous treatment with IL-1ß and TLCK (0 h).
Expression of iNOS Protein
Exposure of VSMCs to IL-1ß for 24 hours was associated with a
substantial level of iNOS protein (Fig 3). However, only
a little iNOS protein was detected in cells that had been exposed to a
combination of IL-1ß and TLCK. The level of iNOS protein was reduced
by 43±11% in cells that were exposed simultaneously to
IL-1ß and aprotinin (Fig 3). In untreated cells and in cells that had
been treated with either TLCK or aprotinin alone, no iNOS protein was
detected (Fig 3).
|
NF-B Binding Activity
EMSAs indicated the presence of low-level NF-B binding activity
in nuclear extracts from unstimulated rat aortic SMCs (Figs 4 and 5). The level of NF-B–DNA
complex increased in a transient manner after exposure of the cells to
IL-1ß (Fig 4). A marked increase in the level of NF-B–DNA complex
was found after only 10 minutes of exposure to IL-1ß. Thereafter, the
signal continued to increase and reached a peak value by 30 minutes.
Afterward, NF-B complex levels decreased to baseline within 4 hours
(Fig 4). Both basal and IL-1ß–stimulated NF-B–DNA binding
activities appeared predominantly as two bands of slightly different
mobility and were competed by excess unlabeled
oligonucleotide, demonstrating the specificity of the
binding to DNA (Fig 4 and data not shown). NF-B binding activity was
reduced in cells that had been exposed to IL-1ß in combination with
increasing concentrations of TLCK for 30 minutes (Fig 5). Exposure of
cells to TLCK alone did not stimulate NF-B binding activity (Fig 5).
|
|
Experiments With Isolated Rat Aortas
Vascular Reactivity Studies
Exposure of aortic rings without endothelium to
IL-1ß for 6 hours caused a marked rightward shift of the
concentration-contraction curve and significantly reduced the maximal
contraction to phenylephrine (Fig 6A). No
such shift and reduction in maximal contraction were obtained with
rings that had been exposed to IL-1ß in combination with TLCK or TLCK
alone for 6 hours (Fig 6A). The possibility that the protective effect
of TLCK on vascular tone was due to inhibition of the cGMP effector
cascade is unlikely, because the NO donor SIN-1 evoked similar
concentration-relaxation curves in control rings and those that had
been incubated with TLCK for 6 hours before the organ chamber
experiments (IC50's were 9.5±2.9x10-7 mol/L
and 5.7±1.7x10-7 mol/L, respectively, without and with
TLCK; Fig 6B).
|
Expression of iNOS mRNA
Southern hybridization of PCR products with an iNOS-specific
probe revealed that exposure of rat aortic segments without
endothelium to IL-1ß for 6 hours was associated with
the appearance of substantial levels of iNOS mRNA (Fig 7). However, only a little iNOS mRNA was detected in
aortic segments that had been exposed to IL-1ß in combination with
TLCK (10-4 mol/L, Fig 7). In untreated aortic segments and
those that had been treated with TLCK alone, no iNOS mRNA was detected
(Fig 7). In RT-PCR reactions without reverse transcriptase, neither
iNOS nor GAPDH PCR products were detectable (data not shown).
|
NF-B Binding Activity
Similar to the findings obtained with cultured rat aortic SMCs,
low-level NF-B binding activity was found in nuclear extracts from
untreated rat aortic rings without endothelium (Fig 8). Exposure of rings to IL-1ß caused a time-dependent
increase in levels of the NF-B–DNA complex, which reached a peak by
30 minutes and persisted thereafter for the next 3.5 hours (Fig 8).
Both basal and IL-1ß–stimulated NF-B binding activities appeared
predominantly as two bands that were competed by excess unlabeled
oligonucleotide, which verified the specificity of the
binding to DNA (Fig 8). NF-B binding activity was reduced in aortic
rings that had been exposed to IL-1ß in combination with TLCK for 30
minutes (Fig 9). Exposure of aortic rings to TLCK alone
did not increase NF-B binding activity (Fig 9).
|
|
|
Discussion |
|---|
|
TopAbstractIntroductionMethodsResultsDiscussionReferences |
|---|
Certain cytokines such as IL-1ß induce expression of iNOS in VSMCs that results in substantial NO production and a depressed contractile response to vasoconstrictor compounds. In the present study, we found that various protease inhibitors inhibited iNOS expression and nitrite accumulation in cultured VSMCs. TLCK, which inhibits neutral proteases by its ability to react covalently with a histidine residue in the active center of these enzymes,34 completely blocked the cytokine-induced formation of NO. Aprotinin, a competitive inhibitor that forms a tight complex with various serine proteases,35 had similar effects though to a lesser extent. L-TAME, a competitive substrate for serine proteases,36 also prevented the induced release of nitrite but only at high concentrations >0.3 mmol/L. In addition, TLCK abolished IL-1ß–induced expression of iNOS and hyporeactivity to phenylephrine in rat aortic rings without endothelium. Altogether, these findings confirm and extend the observations that protease inhibitors of the chloromethylketone group block induction of NO release from a variety of cells other than VSMCs.37 38 39 40 41
The transcriptional activation of both murine and human genes encoding
iNOS is controlled by several common transcription factors that bind to
the upstream promoter region of the iNOS gene.23 24 Among
these transcription factors, a critical activator role has
been attributed to NF-B.23 25 26 27 28 Consistent
with this concept, IL-1ß induced NF-B activity in cultured and
native VSMCs, as indicated by the marked increase in the levels of
NF-B–DNA complexes in nuclear extracts (Reference 4242 and the
present findings). Basal and IL-1ß–stimulated NF-B–DNA
complexes appeared predominantly as two bands of slightly different
mobility (References 42 and 4342 43 and the present findings). Addition
of specific antibodies (directed against either the p65 or the p50
subunit) to nuclear extracts shifted the upper band, whereas the lower
band was shifted by p50 antibodies only, suggesting that the upper band
contained predominantly p65/p50 heterodimers and the lower band p50
homodimers (Reference 4343 and M. Hecker, unpublished data, 1995).
Chloromethylketone derivatives have been shown to
prevent activation of NF-B in murine pre–B lymphocytes, 70Z/3
cells, and Jurkat cells.44 Therefore, it is likely that
inhibition of iNOS expression by protease inhibitors
results from the blocking of the activation of NF-B. In support of
this idea are the findings that the inhibitory effect of
TLCK on IL-1ß–stimulated formation of NO was associated with reduced
NF-B activity in both cultured and native VSMCs. Similar
inhibitory effects of
chloromethylketones have been found in the
IL-1ß–stimulated, insulin-producing rat cell line
RINm5F45 and murine peritoneal macrophages
stimulated by a combination of interferon gamma and
lipopolysaccharide.28 In addition,
chloromethylketones may also affect activation of
other transcription factors necessary for iNOS expression. The
mechanism whereby protease inhibitors block activation of
NF-B and induction of iNOS remains to be established. One
possibility is that these inhibitors prevent the
proteolytic degradation of IB.22 44 As a consequence,
the level of IB remains constant in activated cells, and
IB will continue to "mask" the nuclear localization sequences of
p50 and p65, thereby retaining the transcription factor in the
cytosol.44 Nevertheless, this possibility still needs to
be proved, since we were unable to visualize IB from rat aortic
smooth muscle preparations on immunoblots using three
different polyclonal antibodies raised against human IB (data not
shown). Although the proteases that catalyze the degradation of IB
have not yet been identified, specific proteasome
inhibitors were able to block the inducible degradation of
IB, suggesting involvement of the proteasome
complex.21 46 However, there is evidence that
chloromethylketones have little or no effect on
proteasome activity.47 Thus, the effect of TLCK on NF-B
activation may lie upstream from the proteolysis of IB. Both in
vitro and in vivo investigations have shown that degradation of IB
is preceded by its
phosphorylation.20 22 48 Although this
covalent modification of IB per se is insufficient to release the
inhibitor from NF-B, this step appears to be necessary
for NF-B activation, possibly by modifying IB into an appropriate
substrate for the proteasome complex.46
Chloromethylketones have been shown to prevent
phosphorylation of IB, suggesting that these
compounds may interfere with NF-B activation by inhibiting the
kinase(s) that phosphorylates IB.49 Many
kinases have been reported to phosphorylate IB and
activate NF-B in vitro, including protein kinase C and
cAMP-dependent protein kinase.19 50 Therefore, the
suppressive effect of chloromethylketones, which
are potent alkylating agents, on IB phosphorylation
could be due to their ability to inactivate
adenylate cyclase,51 cAMP-dependent protein
kinase,52 or protein kinase C.53
Consistent with this idea are the findings that
inhibitors of either protein kinase C or cAMP-dependent
protein kinases inhibited iNOS expression in IL-1ß–stimulated
VSMCs.54 55
In conclusion, various types of protease inhibitor were
found to prevent NF-B activation and iNOS expression in cultured and
native VSMCs. These effects may result from direct inhibition of IB
proteolysis or—since IB phosphorylation is an
essential prerequisite for IB degradation—potentially by an
indirect mechanism associated with reduced levels of IB
phosphorylation. Besides the iNOS gene, NF-B also
regulates a variety of other genes that are involved in immune and
inflammatory responses, including those encoding adhesion molecules
(eg, E-selectin, ICAM, and VCAM-1),13 cytokines
and their receptors (eg, IL-1, IL-2, IL-1 receptor, and
IL-6),14 and tissue factor (a protein that triggers the
coagulation protease cascades).56 Thus, protease
inhibitors, by blocking NF-B activation, could be of
therapeutic value for the treatment of the hyperdynamic circulatory
states in sepsis, thrombotic disorders, and inflammatory responses.
|
Selected Abbreviations and Acronyms |
|---|
|
|
Acknowledgments |
|---|
This study was supported by grants from the Deutsche Forschungsgemeinschaft Bu 436/4-3 (to R.B.), Schi 389/1-1 to 3 (to V.B.S.-K.), and a Training Grant from the Land Hessen (to M.B.). The authors thank Dr Agnieszka Bara and Martina Bruckmann for excellent technical assistance.
Received December 12, 1995; accepted June 24, 1996.
|
References |
|---|
|
TopAbstractIntroductionMethodsResultsDiscussionReferences |
|---|
1. Moncada S, Palmer RMJ, Higgs EA. Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol Rev.. 1991;43:109-142. [Medline] [Order article via Infotrieve]
2.
Rees DD, Palmer RMJ, Moncada S. Role of
endothelium-derived nitric oxide in the regulation of
blood pressure. Proc Natl Acad Sci U S A.. 1989;86:3375-3378.
3. Busse R, Lückhoff A, Bassenge E. Endothelium-derived relaxant factor inhibits platelet activation. Naunyn Schmiedebergs Arch Pharmacol.. 1987;336:566-571. [Medline] [Order article via Infotrieve]
4. Garg UC, Hassid A. Nitric oxide-generating vasodilators and 8-bromo-cyclic guanosine monophosphate inhibit mitogenesis and proliferation of cultured rat vascular smooth muscle cells. J Clin Invest.. 1989;83:1774-1777.
5. Xie Q-w, Nathan C. The high-output nitric oxide pathway: role and regulation. J Leukoc Biol.. 1994;56:576-582. [Abstract]
6. Busse R, Mülsch A. Induction of nitric oxide synthase by cytokines in vascular smooth muscle cells. FEBS Lett.. 1990;275:87-90. [Medline] [Order article via Infotrieve]
7. Schini VB, Junquero DC, Scott-Burden T, Vanhoutte PM. Interleukin-1ß induces the production of an L-arginine-derived relaxing factor from cultured smooth muscle cells from rat aorta. Biochem Biophys Res Commun.. 1991;176:114-121. [Medline] [Order article via Infotrieve]
8.
Julou-Schaeffer G, Gray GA, Fleming I, Schott C,
Parratt JR, Stoclet J-C. Loss of vascular responsiveness induced
by endotoxin involves L-arginine pathway. Am J
Physiol.. 1990;259:H1038-H1043.
9.
Joly GA, Schini VB, Vanhoutte PM. Balloon
injury and interleukin-1ß induce nitric oxide synthase activity in
rat carotid arteries. Circ Res.. 1992;71:331-338.
10.
Kilbourn RG, Belloni P.
Endothelial cell production of nitrogen
oxides in response to interferon in combination with tumor necrosis
factor, interleukin-1, or endotoxin. J Natl Cancer
Inst.. 1990;82:772-776.
11.
Werner-Felmayer G, Werner ER, Fuchs D, Hausen A,
Reibnegger G, Wachter H. Tetrahydrobiopterin-dependent formation
of nitrite and nitrate in murine fibroblasts. J Exp
Med.. 1990;172:1599-1607.
12.
Stuehr DJ, Marletta MA. Mammalian nitrate
biosynthesis: mouse macrophages produce nitrite and nitrate in
response to Escherichia coli
lipopolysaccharide. Proc Natl Acad Sci
U S A.. 1985;82:7738-7742.
13.
Collins T. Biology of disease:
endothelial nuclear factor-B and the initiation of
the atherosclerotic lesion. Lab Invest.. 1991;68:499-508. [Medline]
[Order article via Infotrieve]
14.
Baeuerle PA. The inducible transcription factor
NF-B: regulation by distinct protein subunits. Biochim
Biophys Acta.. 1991;1072:63-80. [Medline]
[Order article via Infotrieve]
15.
Blank V, Kourilsky P, Israël A. NF-B
and related proteins: Rel/dorsal homologies meet ankyrin-like
repeats. Trends Biol Sci.. 1992;17:135-140.
16.
Schmitz ML, Henkel T, Baeuerle PA. Proteins
controlling the nuclear uptake of NF-B, Rel, and dorsal.
Trends Cell Biol.. 1991;1:130-137. [Medline]
[Order article via Infotrieve]
17.
Baeuerle PA, Baltimore D. A 65-kD subunit of
active NF-B is required for inhibition of NF-B by IB.
Genes Dev.. 1989;3:1689-1698.
18.
Beg AA, Baldwin AS Jr. The IB proteins:
multifunctional regulators of rel/NF-B transcription
factors. Genes Dev.. 1993;7:2064-2070.
19.
Ghosh S, Baltimore D. Activation in vitro of
NF-B by phosphorylation of its inhibitor
IB. Nature.. 1990;344:678-682. [Medline]
[Order article via Infotrieve]
20.
Beg AA, Finco TS, Nantermet PV, Baldwin AS Jr.
Tumor necrosis factor and interleukin-1 lead to
phosphorylation and loss of IB: a mechanism for
NF-B activation. Mol Cell Biol.. 1993;13:3301-3310.
21.
Palombella VJ, Rando OJ, Goldberg AL, Maniatis T.
The ubiquitin-proteasome pathway is required for processing the
NF-B1 precursor protein and the activation of NF-B.
Cell.. 1994;78:773-785. [Medline]
[Order article via Infotrieve]
22.
Mellits KH, Hay RT, Goodbourn S. Proteolytic
degradation of MAD3 (IB) and enhanced processing of the NF-B
precursor p105 are obligatory steps in the activation of
NF-B. Nucleic Acids Res.. 1993;21:5059-5066.
23.
Xie Q-w, Whisnant R, Nathan C. Promoter of the
mouse gene encoding calcium-independent nitric oxide synthase confers
inducibility by interferon and bacterial
lipopolysaccharide. J Exp Med.. 1993;177:1779-1784.
24.
Chartrain NA, Geller DA, Koty PP, Sitrin NF, Nussler
AK, Hoffman EP, Billiar TR, Hutchinson NI, Mudgett JS. Molecular
cloning, structure, and chromosomal localization of the human inducible
nitric oxide synthase gene. J Biol Chem.. 1994;269:6765-6772.
25.
Xie Q-w, Kashiwabara 
, Nathan C. Role of
transcription factor NF-B/Rel in induction of nitric oxide
synthase. J Biol Chem.. 1994;269:4705-4708.
26.
Mülsch A, Schray-Utz B, Mordvintcev PI,
Hauschildt , Busse R. Diethyldithiocarbamate inhibits
induction of macrophage NO synthase. FEBS
Lett.. 1993;321:215-218. [Medline]
[Order article via Infotrieve]
27. Sherman MP, Aeberhard EE, Wong VZ, Griscavage JM, Ignarro LJ. Pyrrolidine dithiocarbamate inhibits induction of nitric oxide synthase activity in rat alveolar macrophages. Biochem Biophys Res Commun.. 1993;191:1301-1308. [Medline] [Order article via Infotrieve]
28.
Kim H, Lee HS, Chang KT, Ko TH, Baek KJ, Kwon NS.
Chloromethyl ketones block induction of nitric oxide synthase in
murine macrophages by preventing activation of nuclear
factor-B. J Immunol.. 1995;154:4741-4748. [Abstract]
29.
Scott-Burden T, Resink TJ, Baur U, Burgin M, Buhler FR.
Epidermal growth factor responsiveness in smooth muscle cells
from hypertensive and normotensive rats.
Hypertension.. 1989;13:295-304.
30. Grilli M, Chiu JJ, Lenardo MJ. NF-kappa B and Rel: participants in a multiform transcriptional regulatory system. Int Rev Cytol.. 1993;143:1-62. [Medline] [Order article via Infotrieve]
31. Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem.. 1987;162:156-159. [Medline] [Order article via Infotrieve]
32.
Lyons CR, Orloff GJ, Cunningham JM. Molecular
cloning and functional expression of an inducible nitric oxide synthase
from a murine macrophage cell line. J Biol
Chem.. 1991;267:6370-6374.
33.
Tso JY, Sun Xh, Kao TH, Reece KS, Wu R.
Isolation and characterization of rat and human
glyceraldehyde-3-phosphate dehydrogenase cDNAs: genomic
complexity and molecular evaluation of the gene. Nucleic
Acids Res.. 1985;13:2485-2502.
34.
Shaw E, Mares-Guia M, Cohen W. Evidence for an
active-center histidine in trypsin through use of a specific reagent,
1-chloro-3-tosylamido-7-amino-2-heptanone, the chloromethyl ketone
derived from N-tosyl-L-lysine.
Biochemistry. 1965;4:2219-2224.
35. Trautschold I, Werle E, Zickgraf-Rüdel G. Trasylol®. Biochem Pharmacol.. 1967;16:59-72.
36. Scuderi P. Suppression of human leukocyte tumor necrosis factor secretion by the serine protease inhibitor p-toluenesulfonyl-L-arginine methyl ester (TAME). J Immunol.. 1989;143:168-173. [Abstract]
37. Kilbourn R, Lopez-Berestein G. Protease inhibitors block the macrophage-mediated inhibition of tumor cell mitochondrial respiration. J Immunol.. 1990;144:1042-1045. [Abstract]
38.
Dijkmans R, Billiau A.
Interferon-/lipopolysaccharide-treated mouse
embryonic fibroblasts are killed by a glycolysis/L-arginine-dependent
process accompanied by depression of mitochondrial respiration.
Eur J Biochem.. 1991;202:151-159. [Medline]
[Order article via Infotrieve]
39. Jorens PG, Van Overeld FJ, Bult H, Vermeire PA, Herman AG. Serine-protease inhibitors modulate nitric oxide-synthase activity of alveolar macrophages. Agents Actions.. 1992;36:243-247. [Medline] [Order article via Infotrieve]
40. Schmidt HHHW, Warner TD, Nakane M, Förstermann U, Murad F. Regulation and subcellular location of nitrogen oxide synthases in RAW264.7 macrophages. Mol Pharmacol.. 1992;41:615-624. [Abstract]
41.
Welsh N, Eizirik DL, Bendtzen K, Sandler S.
Interleukin-1ß-induced nitric oxide production in
isolated rat pancreatic islets requires gene transcription and may lead
to inhibition of the Krebs cycle enzyme aconitase.
Endocrinology. 1991;129:3167-3173.
42.
Mülsch A, Fisslthaler B, Schini V, Busse R.
Activation of the nuclear transcription factor B is a key
mechanism for nitric oxide synthase gene activation in
macrophages and smooth muscle cells. In:
Moncada S, Feelisch M, Busse R, Higgs EA, eds. The Biology of
Nitric Oxide. London, UK: Portland Press; 1994:142-145.
43.
Lawrence R, Chang L-J, Siebenlist U, Bressler P,
Sonenshein GE. Vascular smooth muscle cells express a
constitutive NF-B-like activity. J Biol
Chem.. 1994;269:28913-28918.
44.
Henkel T, Machleidt T, Alkalay I, Krönke M,
Ben-Neriah Y, Baeuerle PA. Rapid proteolysis of IB- is
necessary for activation of transcription factor NF-B.
Nature.. 1993;365:182-185. [Medline]
[Order article via Infotrieve]
45.
Saldeen J, Welsh N. Interleukin-1ß induced
activation of NF-B in insulin producing RINm5F cells is prevented by
the protease inhibitor N-p-tosyl-L-lysine
chloromethylketone. Biochem Biophys
Res Commun.. 1994;203:149-155. [Medline]
[Order article via Infotrieve]
46.
Traenckner EB-M, Wilk S, Baeuerle PA. A
proteasome inhibitor prevents activation of NF-B and
stabilizes a newly phosphorylated form of IB-
that is still bound to NF-B. EMBO J.. 1994;13:5433-5441. [Medline]
[Order article via Infotrieve]
47.
Hough R, Pratt G, Rechsteiner M. Purification of
two high molecular weight proteases from rabbit reticulocyte
lysates. J Biol Chem.. 1987;262:8303-8313.
48.
Brown K, Park S, Kanno T, Franzoso G, Siebenlist U.
Mutual regulation of the transcriptional activator
NF-B and its inhibitor, IB-. Proc
Natl Acad Sci U S A.. 1993;90:2532-2536.
49.
Finco TS, Beg AA, Baldwin AS Jr. Inducible
phosphorylation of IB is not sufficient for its
dissociation from NF-B and is inhibited by protease
inhibitors. Proc Natl Acad Sci U S A.. 1994;91:11884-11888.
50.
Link E, Kerr LD, Schreck R, Zabel U, Verma I, Baeuerle
PA.Purified IB-ß is inactivated
upon dephosphorylation. J Biol
Chem.. 1992;267:239-246.
51. Needham L, Houslay MD. Tosyl-lysyl chloromethylketone detects conformational changes in the catalytic unit of adenylate cyclase induced by receptor and G-protein stimulation. Biochem Biophys Res Commun.. 1988;156:855-859. [Medline] [Order article via Infotrieve]
52.
Kupfer A, Gani V, Jiménez JS, Shaltiel S.
Affinity labeling of the catalytic subunit of cyclic
AMP-dependent protein kinase by N--tosyl-L-lysine chloromethyl
ketone. Proc Natl Acad Sci U S A.. 1979;76:3073-3077.
53.
Solomon DH, O'Brian CA, Weinstein IB.
N--tosyl-L-lysine chloromethyl ketone and
N--tosyl-L-phenylalanine chloromethyl ketone inhibit protein kinase
C. FEBS Lett.. 1985;190:342-344. [Medline]
[Order article via Infotrieve]
54. Scott-Burden T, Elizondo E, Ge T, Boulanger CM, Vanhoutte PM. Simultaneous activation of adenylyl cyclase and protein kinase C induces production of nitric oxide by vascular smooth muscle cells. Mol Pharmacol.. 1994;46:274-282. [Abstract]
55. Schini-Kerth VB, Boese M, Mülsch A, Busse R. Cyclic AMP plays a critical role in the expression of inducible nitric oxide synthase in vascular smooth muscle cells. In: Moncada S, Stamler JS, Gross SS, Higgs EA, eds. The Biology of Nitric Oxide. London, UK: Portland Press; 1996:66.
56.
Mackman N, Brand K, Edgington TS.
Lipopolysaccharide-mediated transcriptional activation
of the human tissue factor gene in THP-1 monocytic cells requires both
activator protein 1 and nuclear factor B binding
sites. J Exp Med.. 1991;174:1517-1526.
This article has been cited by other articles:
 |
|
 |
|
  S. Kloss, R. Srivastava, and A. Mulsch Down-Regulation of Soluble Guanylyl Cyclase Expression by Cyclic AMP Is Mediated by mRNA-Stabilizing Protein HuR Mol. Pharmacol., June 1, 2004; 65(6): 1440 - 1451. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T.-Y. Chun, L. J. Bloem, and J. H. Pratt Aldosterone Inhibits Inducible Nitric Oxide Synthase in Neonatal Rat Cardiomyocytes Endocrinology, May 1, 2003; 144(5): 1712 - 1717. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Kloss, H. Furneaux, and A. Mulsch Post-transcriptional Regulation of Soluble Guanylyl Cyclase Expression in Rat Aorta J. Biol. Chem., January 17, 2003; 278(4): 2377 - 2383. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Ulker, P. P McKeown, and U. Bayraktutan Aprotinin impairs coronary endothelial function and down-regulates endothelial NOS in rat coronary microvascular endothelial cells Cardiovasc Res, September 1, 2002; 55(4): 830 - 837. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Paparella, T.M. Yau, and E. Young Cardiopulmonary bypass induced inflammation: pathophysiology and treatment. An update Eur. J. Cardiothorac. Surg., February 1, 2002; 21(2): 232 - 244. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Ulker, M. G. Cinar, U. Bayraktutan, and A. Evinc Aprotinin impairs endothelium-dependent relaxation in rat aorta and inhibits nitric oxide release from rat coronary endothelial cells Cardiovasc Res, June 1, 2001; 50(3): 589 - 596. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Kessler, R. Popp, R. Busse, and V. B. Schini-Kerth Proinflammatory Mediators Chronically Downregulate the Formation of the Endothelium-Derived Hyperpolarizing Factor in Arteries Via a Nitric Oxide/Cyclic GMP–Dependent Mechanism Circulation, April 13, 1999; 99(14): 1878 - 1884. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Kessler, J. Bauersachs, R. Busse, and V. B. Schini-Kerth Inhibition of Inducible Nitric Oxide Synthase Restores Endothelium-Dependent Relaxations in Proinflammatory Mediator-Induced Blood Vessels Arterioscler Thromb Vasc Biol, September 1, 1997; 17(9): 1746 - 1755. [Abstract] [Full Text]
|
|
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||